ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 411 filers reported holding ENCOMPASS HEALTH CORP in Q4 2021. The put-call ratio across all filers is 0.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $466 | -5.1% | 6,946 | -4.3% | 0.00% | 0.0% |
Q2 2023 | $491 | +33.1% | 7,257 | +6.3% | 0.00% | 0.0% |
Q1 2023 | $369 | -17.6% | 6,824 | -8.9% | 0.00% | 0.0% |
Q4 2022 | $448 | -99.8% | 7,491 | +19.3% | 0.00% | +100.0% |
Q3 2022 | $284,000 | -70.2% | 6,280 | -62.7% | 0.00% | -75.0% |
Q2 2022 | $952,000 | -25.8% | 16,831 | -6.7% | 0.00% | -20.0% |
Q1 2022 | $1,283,000 | -10.5% | 18,045 | -17.9% | 0.01% | -16.7% |
Q4 2021 | $1,434,000 | +14.3% | 21,974 | +31.4% | 0.01% | +20.0% |
Q3 2021 | $1,255,000 | +23.0% | 16,724 | +27.9% | 0.01% | +25.0% |
Q2 2021 | $1,020,000 | -11.5% | 13,078 | -7.0% | 0.00% | -33.3% |
Q1 2021 | $1,152,000 | -1.2% | 14,067 | -0.2% | 0.01% | 0.0% |
Q4 2020 | $1,166,000 | +45.2% | 14,098 | +14.0% | 0.01% | +20.0% |
Q3 2020 | $803,000 | +12.9% | 12,364 | +7.7% | 0.01% | +25.0% |
Q2 2020 | $711,000 | -3.7% | 11,481 | -0.4% | 0.00% | -33.3% |
Q1 2020 | $738,000 | -7.8% | 11,531 | -0.2% | 0.01% | +20.0% |
Q4 2019 | $800,000 | +10.0% | 11,556 | +0.6% | 0.01% | 0.0% |
Q3 2019 | $727,000 | +26.0% | 11,486 | +26.2% | 0.01% | +25.0% |
Q2 2019 | $577,000 | – | 9,101 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Copeland Capital Management, LLC | 569,048 | $28,117,000 | 1.78% |
Kalos Management, Inc. | 76,118 | $3,761,000 | 1.77% |
Bridge City Capital, LLC | 30,231 | $1,494,000 | 1.08% |
DALTON GREINER HARTMAN MAHER & CO | 331,823 | $16,395,000 | 0.86% |
Horrell Capital Management, Inc. | 28,641 | $1,415,000 | 0.74% |
Polianta Ltd | 26,600 | $1,314,000 | 0.43% |
GLOBEFLEX CAPITAL L P | 30,177 | $1,491,000 | 0.42% |
CARILLON TOWER ADVISERS, INC. | 768,748 | $37,984,000 | 0.40% |
EAGLE ASSET MANAGEMENT INC | 1,070,271 | $53,001,000 | 0.29% |
S. R. Schill & Associates | 8,108 | $401,000 | 0.25% |